The G protein-coupled receptor LGR5 has also been reported to be a marker for colorectal CSCs during the initial stages of tumorigenesis, and LGR5 expression levels correlated with aggressive clinicopathological features in colorectal cancer [71,72,73]. The gene discussed is LGR5; the disease is colorectal cancer.